| Pharmaceutical active ingredients: |
| Atazanavir Sulfate |
| Available forms, composition and doses of Reyataz: |
| Capsules; Oral; Atazanavir Sulfate 100 mgCapsules; Oral; Atazanavir Sulfate 150 mgCapsules; Oral; Atazanavir Sulfate 200 mgCapsules; Oral; Atazanavir Sulfate 300 mg |
| Reyataz medical category: |
| Human:AntiviralsHIV protease inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AE08 - Atazanavir |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbDKSH |
| Related documents and information about Reyataz: |
| Reyataz prescribing information (PDF) |